Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee System
← catalyst calendarNCT03078543 · readout in 985 d
Sponsored by Smith & Nephew, Inc. (industry) · SNN — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
148actual
Sites
8
Countries
China, Italy, South Africa +2
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2017-06-28 | actual | When the study began enrolling |
| Primary completion | 2029-04-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-04-30 | estimated | The whole study's end, after follow-up |
| First posted | 2017-03-13 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-03-11 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Arthroplasty, Replacement, Knee
Intervention
- Device: ANTHEM™ PS Total Knee System implant
Primary outcome
what the primary-completion date above is the date OFTen year Anthem knee implant survivorship
measured Study participants will be followed for 10 years
Permalink · SNN's whole pipeline · Catalyst calendar · Every registered study · What changed